Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Holders of 5% or more of LPCN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lipocine Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | 13G/A | 9.50%530.0K shares | +0.50 ppfrom 9.00% | Dec 23, 20252 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Lipocine Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 202611:49 AM ET | Squadron Capital Management LLCand 3 others | 13G/A | 9.50%530.0K shares | +0.50 ppfrom 9.00% | Dec 31, 2025 | SEC |
| Dec 23, 20253:49 PM ET | Squadron Capital Management LLCand 3 others | 13G | 9.00%500.0K shares | New | Dec 18, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lipocine Inc. shares.
No Form 144 notices for Lipocine Inc. are on file.